Cynthia Smith, Director at Akebia Therapeutics, Inc. (AKBA), bought 15,000 shares at $3.52 ($53K) on 2019-11-20, disclosed to the SEC on 2019-11-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.